Fred Brown Email & Phone Number

Baltimore, US

Develop AI-based risk stratification and care-pathway SaaS tools to manage Social Security Disability Insurance and social determinants of health for over 2.2 million Americans. Leading predictive analytics tool for providers, health plans, benefit, health, life and stop-loss insurers and self insured employers to manage populations and individuals with.

Oslo, NO

Support public/private alliances to finance and coordinate the development and supply of new vaccines and other countermeasures to prevent and contain infectious disease epidemics. Creating new sustainable business models, de-risked financing, vaccine (DVT) innovations, healthy markets, technology workforce and training programs, supply chain; WHO,WTO and.

Cologny, Geneva, CH

I am co-leading the Regional Vaccine Manufacturing Collaborative (RVMC) of the WEF chaired by CEPI and the US National Academy of Medicine. The RVCM aims to increase vaccine access for low- and middle-income countries through successful and sustainable establishment of a versatile global vaccine manufacturing network capable of producing vaccines during.

Member of the Board of Directors for a privately-held, research-stage, drug delivery company focused on delivering cancer chemotherapy and other established drugs with a limited therapeutic window to tumors and affected organs. Over $5M raised. Two drug candidates entering human clinical trials in 2024. Member of Scientific Advisory Board and Compensation.

Ann Arbor, Michigan, US

Warmilu manufactures non-electric warming blankets to prevent hypothermia in infants. Every year our warming solutions save the lives of over 15,000 infants in almost 100 countries where electricity is not available. We are the preferred solution of Doctors Without Borders and the International Rotary Club.

Worldwide, OO

Life Sciences and Healthcare Practice Manager. Specialize in digital and biomedical tech transformation, focusing on the clinical development, market launch and commercial optimization of next-gen biopharmaceutical and med-tech products. Led the global redesign of the Essential Medicine supply chains for the U.S/FDA, EU/EMA, the Japanese Ministry of Health.

• C-suite strategy and operations consulting to healthcare providers, insurers and suppliers.Operation Warp Speed - Senior Advisor to 2 administrations. Led regulatory strategy for vaccine EUA acceleration for nine DVT.
• Predictive Analytics and AI Population HIT Company – Funding by BCBS Association and Intel to develop AI-based analytical models that predict individual and population clinical conditions. Savings of $700PMPY achieved.
• Major Life Sciences Company – Led product roll-out and expansion into new channel. Negotiated channel partnerships, developed reimbursement strategy and developed internal sales team. Achieved $200M additional sales in.
• COO of clinical trial network and registry company leading real-life trials, and outcomes research. Led PD1 inhibitor pivotal trial network. Global operations in 16 countries. Managed P&L, personnel deployment, product.
• Leading Academic Medical Center - Office of Strategic Program Management: Opened new PMO reporting to Executive Council to re-engineer operations across academic health system. Launched PMO lifecycle methodology..
• C-Suite, Leading Global Clinical Research Organization: Led launch of new $200M Solutions Division for leading Contract Research Organization. Drove solutions and contracted new work. Transitioned delivery teams and.

Member of the Board of Directors and R&D Partnerships and Audit Subcommittees of leading hepatic, metabolic and organ modelling biopharmaceutical company from initial raise through Series C capitalization - over $40M raised. Helped commercialize Reveal-Tx solution offering to the CRO and pharma industry, hire executive and scientific teams, initiate and.

St. Louis, MO, US

• Newly created position reporting to System CEO, responsible for all strategy planning, innovation and business development for Michigan Market. Executive Change Agent across the system of care. Board Member of 3.
• Led regional annual strategy and budgeting teams and process.
• Oversaw internal and external joint ventures and partnerships. Led private equity partnering and fund raising to support acquisition of new care technologies, products and services across the network.
• Sponsored internal and external innovation programs in medicine, informatics, regulatory compliance, and new business models.
• Supported Pioneer ACO program, grew physician networks, launched national home care operations and continuum of care programs, expanded insurance risk-sharing and awarded meaningful-use monies across the network.
• Established a comprehensive change program of over 70 projects and JV’s that grew the system market value 30% in five years, and supported access to external PE funding.

Troy, MI, US

• Developed global client base across new healthcare supply, provider and insurance companies to become the 7th largest M&A advisory in the state of Michigan. Led several new business launches for healthcare clients, as.
• Negotiated and implemented a $3.5B merger of a biotech and major pharmaceutical company.
• Evaluated new product extension opportunities in BRIC countries for a major healthcare company.
• Assessed the financial and strategic impact of PPACA regulations on healthcare suppliers, providers and payors.

Flint, Michigan, US

• Led Diplomat Specialty Pharmacy, world’s largest independent specialty pharmacy, in raising $200M of non-dilutive funding. Developed and sold outsourcing services and consulting to research hospitals, CROs, biotech and.
• Raised $200M of external capital to execute growth strategy and grew sales to $670M, improving EBITDA over 25%.
• Diplomat awarded Inc. Magazine “Fastest Growing Healthcare Company" -- 2009.

Global, US

1997 - 2001. Led launch of CSC Life Sciences and Healthcare in Europe. Designed strategy and built business from scratch, growing sales to over $100M and increasing team from 3 to over 40 consulting professionals. Developed industry-wide, global reputation for excellence in Healthcare PLM, clinical development project management, regulatory compliance, and.

Switzerland 🇨🇭, CH

Championed new portfolio and partnering strategy to increase overall corporate profitability by 7%. Led Global 200-person staff with annual budget of $100M with strategic mission of profit optimization of the Pharmaceutical Division portfolio. Also led teams supporting all Roche external partnerships and project management, which involved over 70 business.

Armonk, New York, NY, US

Responsible for Watson/Life Sciences business in EMEA. Hired and led over 1000 professionals, becoming largest healthcare services organization in Europe. Grew sales to $1.2B in 3 years across 62 countries in Europe, Middle East and Africa (EMEA). Maintained profit contribution of over 35% and was #1 growth business division in all of IBM. Managed client.

Dublin 2, IE

Co-founded the Pharmaceutical and Medical Products Practice (PMP). Created strategy and business plan, developed thought capital and methodologies, built team, and sold and delivered projects. Grew NA Practice to 250 professionals and $385M in 5 years; and then Continental Europe to 125 professionals and $250M.

Dublin, IE

Co-founded pharmaceutical company (NASDAQ: ALKS) that has become the world's largest in depo injection, drug formulation and delivery company with 20 marketed products and $5B in assets.

Mba | Master Of Business Administration, Business Administration And Management, General

Bs | Bachelor Of Science, Biology & Geology